Skip links


PharmaCielo Processing & Extraction Center photo

PharmaCielo Announces Closing of $10M Private Placement

TORONTO, Ontario (November 23, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) is pleased to announce the closing of its previously announced private placement of units ("Units") of the Company for gross proceeds of $10.0 million. “The closing of this offering further strengthens the Company’s balance sheet
Mexico flag

PharmaCielo Mexico Salutes Mexican Senate for Advancing Cannabis Legalization

TORONTO, Canada and MEXICO CITY, Mexico (November 19, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) and MINO Labs S.A. de C.V. (“MINO Labs”), the founders of PharmaCielo S.A. de C.V. (“PharmaCielo Mexico”), congratulate Mexican Senate members for advancing the much-needed cannabis legislation and subsequent reform
PharmaCielo greenhouses

PharmaCielo Begins Harvest of High-THC Cultivars for Extract Export

First harvest cycle of high-THC cultivars expected to yield more than 10 tonnes of dry flower for extract processing Extracts from six psychoactive cultivars part of Company’s expanded product portfolio announced in mid-September Company holds Government approval for commercial export of high-THC extracts TORONTO, Canada
PharmaCielo logo

PharmaCielo Announces Upsizing of Private Placement Offering

Not for distribution to United States newswire services or for dissemination in the United States TORONTO, Ontario (November 3, 2020) – PharmaCielo Ltd. (“PharmaCielo” or the “Company”) (TSXV: PCLO, OTCQX: PCLOF) is pleased to announce that, due to high demand, it has increased the size of its previously